neoplasm
• leukemia tumor development penetrance is 87%
• mice intraperitonally injected with MMLV show accelerated pre-B-cell leukemia formation compared to controls
|
• 40% of mice develop B-cell acute lymphoblastic leukemia
• however, mice do not develop T-cell acute lymphoblastic leukemia, myeloid leukemia, or mixed B-cell/myeloid leukemia
• B-cell leukemia development is accelerated compared to single Tg(Tcrb-TCF3/PBX1)23Gusa transgenic mice
• B-cell tumors are B220+/CD43-/CD19+/IgM-/Pax5+, indicating a pre-B-cell phenotype, and contain IgH chain rearrangements, mostly of the kappa light chain
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
acute leukemia | DOID:12603 |
OMIM:308960 |
J:95693 |